尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Pfanstiel Steven, 首席财务官. Officer active across 3 companies, notably Marinus Pharmaceuticals INC. Cumulatively, 14 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €77k. Activity tracked since 4 February 2022. The latest transaction was filed on 19 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Pfanstiel Steven is Directeur Financier. The record shows 14 filings in total. Across the 14 most recent sampled filings, there were only sales, for a total of EUR 85977, over the period from 2022-02-07 to 2026-03-24. The companies mentioned are Marinus Pharmaceuticals, INC., Marinus Pharmaceuticals INC and Neuronetics, Inc., and the modal transaction nature is Attribution.